Table 2.
Nanoparticles/composites | Size | Surface coating | Dosage rate and exposure time | Model (cells/animals) | Comments on toxicity (effect on cells, organs, tissues/cell viability) | References |
---|---|---|---|---|---|---|
Nanospheres | 2 nm | — |
0.38–3 × 10−6 m; 1, 2.5, 6, 24 h |
COS‐1 | Cationic particles are moderately toxic, whereas anionic particles are nontoxic facilitated by their strong electrostatic attraction to the negatively charged bilayer | [ 229 ] |
Nanorods | 4 nm | Chitosan on the surface | 50 µg mL−1, 24 h | Mice | Improved in vitro cellular uptake and minimal toxic effects were observed | [ 230 ] |
Bifunctional Au/Ni NRs | 20 µm long and 170 nm in diameter | — |
44 mg mL−1 4 h |
HEK293 | Reduced risk of cytotoxicity and immunogenicity. | [ 231 ] |
Nanospheres | 3.5 ± 0.7 nm | — |
10, 25, 50, and 100 × 10−6 m 24, 48, and 72 h |
RAW264.7 | Au NPs are not cytotoxic, reduce the production of reactive oxygen and nitrite species, and do not elicit secretion of proinflammatory cytokines TNF‐α and IL1‐β, making them suitable candidates for nanomedicine. | [ 232 ] |
Nanospheres | 2, 10, 25, 40, 50, 70, 80, and 90 nm | Herceptin physical adsorption |
10 µg mL−1 3 h |
SK‐BR‐3, SNB‐19, and HeLa cells | Gold and silver NPs coated with antibodies can regulate the process of membrane receptor internalization | [ 233 ] |
Nanoshperes | 50 and 100 nm | Tiopronin |
1 nmol L−1 3–24 h |
MCF‐7 | Optimal smaller size for NPs that maximizes their effective accumulation in tumor tissue. | [ 234 ] |
Nanospheres | 4, 12, and 17 nm | L‐cysteine |
10 × 10−9 m 3 h |
HeLa | Both the uptake and unbinding force values are dependent upon the size of gold NPs. | [ 235 ] |
Nanorods | CTAB, PEG‐SH |
0.01–0.5 × 10−3 m 24 h: In vitro (0.5–0.9 × 10−3 m in vivo) 0.5, 3, 6, 12, 24, and 72 h: In vivo |
HeLa/mice | PEG‐modified gold NPs showed a nearly neutral surface and had little cytotoxicity in vitro. Following intravenous injection into mice, 54% of injected PEG‐modified gold NPs were found in blood at 0.5 h after intravenous injection, whereas most of gold was detected in the liver in the case of original gold NRs stabilized with CTAB. | [ 236 ] | |
Nanostars | 110 10 nm | GNS SiO2/Au |
10 mg g−1 4 h, 1, 4, 7, 14, 21, 28 d |
Mice IV; | The mass of gold in the tissue samples ranged from our determination limit (about 70 pg) to a few micrograms. | [ 237 ] |
Nanowires |
0.58, 1.8, 4.5, 8.6 nm_X 200 nm |
Thiols with amino, alkyl, or carboxyl end groups, serum | 103–106 particles mL−1, 24 h | NIH 3T3 | Internalized nanowires with high aspect ratios are more toxic to cells than nanowires with low aspect ratios. | [ 238 ] |
Nanoclusters | 0.8, 1.2, 1.4, 1.8, CG‐15 | Triphenylphosphine |
1–10 000 × 10−6 m 6, 12, 18, 24 h |
HeLa Sk‐Mel‐28 L929 J774A1 |
Gold particles 15 nm in size and Tauredon (gold thiomalate) are nontoxic at up to 60‐fold and 100‐fold higher concentrations, respectively. The cellular response is size‐dependent, in that 1.4 nm particles cause predominantly rapid cell death by necrosis within 12 h while closely related particles 1.2 nm in diameter effect predominantly programmed cell death by apoptosis. | [ 194 ] |
Nanoclsuters | 1.4 nm | — |
Mice: 57 mg, Rat: 285 mg Mice: 2, 4, 24 h Rat: 3, 7, 10 d |
Mice, Rat | clusters reach a polydentate ligand sphere that increases the kinetic stability by orders of magnitude | [ 195 ] |
Nanoparticles | 12.5 nm | — |
IP; 40, 200, 400 mg kg−1 day−1 8 d |
Mice | AuNPs are able to cross the blood–brain barrier and accumulate in the neural tissue. Importantly, no evidence of toxicity was observed in any of the diverse studies performed, including survival, behavior, animal weight, organ morphology, blood biochemistry and tissue histology. | [ 239 ] |